Silvestri B, Calderazzo F, Coppola V, Rosato A, Iacobelli S, Natoli C, Ullrich A, Sures I, Azam M, Brakebush C, Chieco-Bianchi L, Amadori A
Department of Oncology and Surgical Sciences, Interuniversity Centre for Research on Cancer, University of Padova, Italy.
Clin Exp Immunol. 1998 Sep;113(3):394-400. doi: 10.1046/j.1365-2249.1998.00654.x.
We studied the effects of a 90-kD glycoprotein (gp90/Mac-2BP) belonging to the scavenger receptor family, present in normal serum and at increased levels in inflammatory disease and cancer patients, on some T cell function parameters. Whereas the lymphocyte proliferative response to non-specific mitogens such as phytohaemagglutinin (PHA) and concanavalin A (Con A), but not pokeweed mitogen (PWM), was strongly reduced, probably due to the lectin-binding properties of gp90/Mac-2BP, the response to T cell receptor (TCR) agonists such as superantigens and allogeneic cells was potentiated. When lymphocytes were stimulated with different anti-TCR:CD3 MoAbs, both in soluble and solid-phase form, gp90/Mac-2BP was able to down-regulate the proliferative response to anti-CD3 MoAb, whereas the response to anti-TCR alphabeta MoAb was enhanced. A similar differential effect was observed when a MoAb against CD5 (another member of the scavenger receptor superfamily) was added to anti-CD3 or anti-TCR-stimulated cells; anti-CD5 MoAb strongly down-modulated the CD3-mediated response, whereas its presence in culture was associated with potentiation of the response to TCR alphabeta agonists. gp90/Mac-2BP was able per se to up-regulate Ca2+ levels in freshly isolated lymphocytes; moreover, its presence in culture was associated with increased Ca2+ mobilization following stimulation with anti-TCR alphabeta, but not anti-CD3 MoAb. These data indicate that gp90/Mac-2BP could be able to influence some immune responses, possibly through multiple homologous interactions with other members of the scavenger receptor family; moreover, our findings suggest that signalling through the different components of the TCR:CD3 complex may follow distinct activation pathways into the cells.
我们研究了一种属于清道夫受体家族的90-kD糖蛋白(gp90/Mac-2BP)对某些T细胞功能参数的影响。该蛋白存在于正常血清中,在炎症性疾病和癌症患者体内水平升高。虽然淋巴细胞对诸如植物血凝素(PHA)和刀豆蛋白A(Con A)等非特异性有丝分裂原的增殖反应,但对商陆有丝分裂原(PWM)无此反应,受到强烈抑制,这可能归因于gp90/Mac-2BP的凝集素结合特性,而对T细胞受体(TCR)激动剂如超抗原和同种异体细胞的反应则增强。当用不同的抗TCR:CD3单克隆抗体(MoAbs)以可溶性和固相形式刺激淋巴细胞时,gp90/Mac-2BP能够下调对抗CD3 MoAb的增殖反应,而对抗TCRαβ MoAb的反应增强。当将抗CD5(清道夫受体超家族的另一个成员)的MoAb添加到抗CD3或抗TCR刺激的细胞中时,观察到类似的差异效应;抗CD5 MoAb强烈下调CD3介导的反应,而其在培养物中的存在与对TCRαβ激动剂反应的增强相关。gp90/Mac-2BP本身能够上调新鲜分离淋巴细胞中的Ca2+水平;此外,其在培养物中的存在与用抗TCRαβ刺激后而非抗CD3 MoAb刺激后的Ca2+动员增加有关。这些数据表明,gp90/Mac-2BP可能能够通过与清道夫受体家族的其他成员进行多种同源相互作用来影响某些免疫反应;此外,我们的研究结果表明,通过TCR:CD3复合物的不同组分进行信号传导可能遵循进入细胞的不同激活途径。